The European Union will continue international cooperation with the U.S. on the development and production of coronavirus vaccine, despite Washington's refusal to join the international initiative COVAX. This was announced on Wednesday by the representative of the European Commission (EC) Vivian Lunela.
вЂњThe European Union will continue international cooperation with the U.S. on vaccine development and production,вЂќ she said when asked about the U.S. refusal to participate in the COVAX initiative on coronavirus vaccine development, production, and distribution. Lunela recalled that the EU had decided to join COVAX, providing в‚¬400 million in financial guarantees for its implementation.
On Tuesday, White House Deputy Spokesman Judd Deere said the United States would not participate in the international initiative COVAX, which, he said, вЂњis under the influence of the corrupt World Health Organization.
The COVAX project is managed by the Global Alliance for Vaccines and Immunization (GAVI), the Coalition for Epidemic Preparedness Innovation (CEPI), WHO, and multinational pharmacological vaccine manufacturers who see the tool as an additional source of government funding. The goal of the mechanism is to invest in about 12 different vaccines and provide вЂњfair early accessвЂќ to them when they become available on the market. By the end of 2021, about 2 billion doses of the vaccine are expected to be distributed with the help of COVAX. The WHO Director-General said last week that 172 countries have already joined the mechanism.